Literature DB >> 2709294

Total colectomy and ileorectal anastomosis in the treatment of total colonic aganglionosis: a long-term follow-up study of six patients.

J H Bergmeijer1, D Tibboel, J C Molenaar.   

Abstract

Six patients with total colonic aganglionosis (TCA) with ileal involvement were treated with a total colectomy and ileorectal anastomosis according to Rehbein. Follow-up lasted from 1 to 7 years and showed no mortality. Postoperative management consisted of total parenteral nutrition initially, followed by gradual introduction of oral feeding beginning with a low-osmolarity low-residue diet, the use of loperamide, an adequate oral intake of salt, and regular bowel deflation. Major postoperative complications disappeared and all patients demonstrated weight gain by the end of the first postoperative year, with normal feeding and two to three soft stools per day.

Entities:  

Mesh:

Year:  1989        PMID: 2709294     DOI: 10.1016/s0022-3468(89)80013-2

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

1.  Early definitive surgery for total colon aganglionosis: Duhamel procedure with right colon patch graft using GIA stapler.

Authors:  I Yamagiwa; K Obata; M Kohi
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

Review 2.  Total colonic aganglionosis: a systematic review and meta-analysis of long-term clinical outcome.

Authors:  Danielle Mc Laughlin; Florian Friedmacher; Prem Puri
Journal:  Pediatr Surg Int       Date:  2012-08       Impact factor: 1.827

3.  Total colonic aganglionosis: a surgical challenge. How to avoid complications?

Authors:  Andrea Bischoff; Marc A Levitt; Alberto Peña
Journal:  Pediatr Surg Int       Date:  2011-10       Impact factor: 1.827

4.  Surgical treatment of children with total colonic aganglionosis: functional and metabolic long-term outcome.

Authors:  Cristian Urla; Justus Lieber; Florian Obermayr; Andreas Busch; Roland Schweizer; Steven W Warmann; Hans-Joachim Kirschner; Jörg Fuchs
Journal:  BMC Surg       Date:  2018-08-15       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.